Celiac Diseases Drugs Market Size 2024-2028

The global celiac diseases drugs market size is estimated to grow by USD 1.10 billion at a CAGR of 21.21% between 2023 and 2028. The market is influenced by a higher consumption of gluten-containing foods, coupled with an increasing prevalence of celiac disease, prompting governmental initiatives. The growing intake of gluten-rich foods underscores dietary habits, while the rising incidence of celiac disease necessitates healthcare responses and regulatory measures. Government initiatives play a crucial role in addressing public health concerns related to gluten intolerance and promoting awareness about gluten-free diets. These factors collectively shape consumer behavior and industry practices, driving demand for gluten-free products and influencing food manufacturing and labeling standards. As awareness spreads and health considerations evolve, stakeholders across healthcare, food production, and regulatory sectors collaborate to meet the needs of individuals with celiac disease and cater to the broader market seeking gluten-free alternatives.

Technavio has segmented the market into therapy, route of administration, and geography

• The therapy  segment is classified into first line treatment and second-line treatment
• The route of administration  segment is classified into oral and parenteral
• The geography segment includes key regions such as North America, Europe, Asia, and Rest of World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2017 to 2021, besides analyzing the current market scenario.

What will be the size of the Celiac Diseases Drugs Market During the Forecast Period?

To learn more about this report, Request Free Sample

Market Segmentation 

By Therapy   

The market share growth by the first line treatment segment will be significant during the forecast period. For celiac disease, the first line of treatment includes treatments that are mainly associated with the prevention and cure of the disease. This segment included a gluten-free diet, which is now an available choice for the prevention of triggering immune responses leading to different clinical manifestations. 

Get a glance at the market contribution of various segments View a PDF Sample

The first line segment was the largest and was valued at USD 352.30 million in 2018. The first line of treatment is presently dominated by a gluten-free diet as this is the only available option for the prevention of immune response. Furthermore, the current volume-driven market is expected to change into a value-driven market upon the successful launch of a few novel late-stage pipeline molecules. However, due to economic constraints, these new launches will find it challenging to penetrate the low economic regions, which could restrict market growth. Therefore, the segment is anticipated to experience significant growth, thereby fueling the growth of the market during the forecast period.

Route Of Administration Analysis 

Oral

Oral routes of administration are becoming increasingly popular in the global celiac disease drug market due to their simplicity and patient compliance. Oral medicines have gained huge acceptance as an effective approach to controlling celiac disease, addressing symptoms, and lowering inflammation in the digestive tract. Further, in severe situations, oral immunosuppressants such as azathioprine (Imuran) may be administered to control the immunological response. Such a trend is expected to continue as pharmaceutical companies spend on R&D to generate more new oral medicines that enhance the quality of life for celiac disease patients. This, in turn, will drive the growth of the market during the forecast period.

Parenteral

Parenteral administration has seen steady expansion in the global celiac disease drugs market due to the limited effectiveness of oral therapies for this autoimmune disease. Celiac disease, which is characterized by gluten intolerance, necessitates precision medicine delivery to treat symptoms and prevent complications. Further, to suppress the inflammation during the acute phases of the condition, corticosteroids such as prednisone can be injected intravenously or intramuscularly. The increased awareness of celiac disease and the development of novel parenteral therapeutics are expected to fuel additional growth in this market segment. Due to this growth trend, the market is expected to witness growth during the forecast period.

Regional Analysis

For more insights about the market share of various regions View PDF Sample now!

North America is estimated to contribute 58% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. In 2022, North America held the highest share of the global celiac disease drugs market. The market is expected to grow due to factors such as the rising prevalence of celiac diseases, growing awareness of celiac diseases, the presence of key companies, and a strong pipeline of drugs in the region. Due to the increase in the consumption of gluten-containing food, the prevalence of the disease is growing in the US. The consumption of beer and fast food is increasing in the region, which is a major risk factor for celiac disease.

For instance, around 63% of American adults drink alcohol, and their favored beverage is beer. Around 42% of American drinkers prefer beer and its high consumption is a major risk factor for celiac disease. Also, fast-food consumption is growing in the region due to busy work life and a growing preference for ready-to-eat food. Therefore, the high consumption of gluten-containing food and the growing prevalence of celiac diseases are anticipated to drive the growth of the regional market during the forecast period.

Buy Now Full Report and Discover More

Key Celiac Diseases Drugs Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Adaptive Biotechnologies Corp. - The company offers celiac disease drugs such as Immunoseq dx, Pairseq and Trutcr.

• 9 Meters Biopharma Inc.
• Almirall SA
• Amgen Inc.
• AMYRA Biotech AG
• Artielle Immunotherapeutics Inc,
• Avaxia Biologics Inc.
• BioLineRx Ltd.
• Bristol Myers Squibb Co.
• Calypso Biotech BV
• GlaxoSmithKline Plc
• Glenmark Pharmaceuticals Ltd.
• ImmunogenX Inc.
• Johnson and Johnson
• Precigen Inc.
• Sanofi
• Takeda Pharmaceutical Co. Ltd.
• Teva Pharmaceutical Industries Ltd.
• Vactech Oy
• Zedira GmbH

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Dynamics

Coeliac disease, a genetic disorder affecting the small intestine, is triggered by the consumption of gluten-rich foods found in wheat, barley, and rye. This autoimmune condition results in gastrointestinal malfunction, leading to symptoms such as diarrhea, abdominal distention, and loss of lymphocytes. Beyond gastrointestinal issues, Coeliac disease can manifest in diverse ways, including neurological disorders, low bone density, and even infertility due to its autoimmune nature. The increasing prevalence of this condition prompts significant healthcare expenditure globally, driving advancements in drug formulation technology by pharma companies. As awareness grows, ready-to-use packaged foods labeled as gluten-free cater to individuals with Coeliac disease and those with non-Celiac gluten sensitivity. Effective management involves comprehensive healthcare systems addressing both pharmaceutical interventions and dietary adjustments to alleviate symptoms and improve the quality of life for affected individuals.

Key Celiac Diseases Drugs Market Drivers

Higher consumption of gluten-containing food is notably driving the market growth. Due to the high consumption of food containing gluten, celiac disease is characterized by an increase in gluten deposition in the body. Pizza, cake, soups, beer, bread, cookies, pasta, and burgers are some of the widely consumed foods that contain gluten. Globally, the consumption of fast food such as pizza and burgers is increasing. For instance, in the US, the consumption of pizza is at a moderate level.

Moreover, the rise in per capita income, changing lifestyle, addiction toward junk food and beverages, and the introduction of ready-to-use packaged eateries have contributed to the upsurge in the consumption of gluten-containing food. Thus, The chances of acquiring celiac disease are also high due to the high consumption of gluten-containing food. These factors are anticipated to fuel the growth of the market during the forecast period.

Significant Celiac Diseases Drugs Market Trends

Increasing promising developments in celiac treatment is an emerging trend shaping the market growth. Nowadays, for celiac disease management, there is no approved drug indicated. However, the current pipeline is robust. Such drugs are anticipated to be approved and launched during the forecast period. With higher impacts, these drugs will change market dynamics.

Moreover, these drugs act by various mechanisms (s) and with various approaches to treating celiac diseases at multiple targets. These drugs will drive the market and change the current market dynamics during the forecast period.

Major Celiac Diseases Drugs Market Challenges

The complexity of the disease is a significant challenge hindering market growth. Celiac disease is associated with a variety of symptoms and these symptoms are associated with various organs throughout the body. These symptoms make the disease more intricate and, therefore, difficult to manage. Similarly, celiac disease is a multisystem disorder that impacts various human organs.

Moreover, they may face immune-mediated disorders while consuming gluten in cases where celiac disease is hereditary, and celiac disease drugs may not be effective in such cases. Therefore, such factors may adversely influence the growth of the market during the forecast period.

Buy Now Full Report and Discover More

Key Celiac Diseases Drugs Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Celiac Diseases Drugs Market Customer Landscape

Segment Overview

The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Million" for the period 2024 to 2028, as well as historical data from 2018 to 2022 for the following segments. 

• Therapy Outlook
  • First line treatment
  • Second-line treatment

• Route Of Administration Outlook
  • Oral
  • Parenteral

• Region Outlook
  • North America
    • The U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
  • ROW
    • Brazil 
    • Argentina
    • Australia

You may also interested in below market reports:

Gastrointestinal (GI) Diseases Therapeutics Market: Gastrointestinal (GI) Diseases Therapeutics Market Analysis North America, Asia, Europe, Rest of World (ROW) - US, Germany, France, Japan, China - Size and Forecast

Biologics Contract Development and Manufacturing Organization (CDMO) Market: Biologics Contract Development and Manufacturing Organization (CDMO) Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, France, China, Japan - Size and Forecast 

Autoimmune Disease Diagnostics Market;  Autoimmune Disease Diagnostics Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, UK, Germany, Japan - Size and Forecast 

Market Analyst Overview

Celiac disease, an autoimmune disorder triggered by gluten-rich foods, presents significant challenges in diagnosis and treatment. Governments, private organizations, and pharmaceutical companies are actively involved in drug approval and celiac drug innovation, addressing an unmet medical need for effective therapies. Diagnostic options include blood tests measuring anti-tissue transglutaminase antibodies and small bowel biopsy for confirmation. Clinical trials assess new pharmaceutical treatments and immunomodulatory therapies, aiming to manage symptoms like bowel disorders, bloating, and malnutrition associated with celiac disease. Genetic markers and immune profiles aid in understanding patient responses and developing personalized treatments. Despite progress, challenges like misdiagnosis and managing complications such as diabetes type 1 and infertility persist. Drug delivery technology advancements and gluten-free diet plans are pivotal in improving patient outcomes. Collaborative efforts among universities, healthcare professionals, and pharmaceuticals are essential in enhancing diagnostic accuracy and treatment efficacy for a diverse patient pool affected by this chronic condition.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Market Forecast Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting of the market between 2024 and 2028
• Precise estimation of the market size and its contribution to the parent market
• Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
• Growth of the market across Europe, North America, APAC, South America, and Middle East and Africa
• Thorough market growth analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive market analysis and report on the factors that will challenge the market research and growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch